Arthrosamid® injectable hydrogel
Ultrasound-guided injectable hydrogel for knee osteoarthritis. Ask the clinician about eligibility, risks and alternatives; outcomes vary.
Ultrasound-guided Arthrosamid for knee osteoarthritis, £2,300 at Sheffield and Cowes. Read about assessment, the permanent implant and potential risks.
Arthrosamid is an injectable hydrogel option for knee osteoarthritis. Rapid Joint Relief offers an ultrasound-guided Arthrosamid service at £2,300 in both Sheffield and Cowes.
An assessment comes first and an injection is only given if clinically appropriate. Arthrosamid is not suitable for everyone. Results vary and are not guaranteed. It is intended to help manage symptoms, not cure osteoarthritis, and it should be discussed alongside risks and alternatives before a decision.
Ultrasound-guided injectable hydrogel for knee osteoarthritis. Ask the clinician about eligibility, risks and alternatives; outcomes vary.
The existing patient information describes Arthrosamid as intended for the symptomatic treatment of adults with knee osteoarthritis. That intended use is not confirmation that it is appropriate for you. You can bring an existing diagnosis and your questions to a consultation.
The manufacturer presentation lists exclusions including infection near the injection site, an infected or severely inflamed joint, a knee replacement or other foreign material in the knee, and previous non-absorbable joint implants. It also discusses previous knee procedures and anticoagulant treatment. This summary is not a substitute for full screening.
The pricing information describes a permanent injectable hydrogel implant rather than a corticosteroid or hyaluronic acid injection. The manufacturer describes it as integrating into the synovial tissue, the lining inside the knee joint. Its permanent nature is an important part of the suitability and risk discussion.
The existing presentation describes an outpatient procedure using local anaesthetic, with antibiotics prescribed before treatment to reduce infection risk. At Rapid Joint Relief the listed Arthrosamid service is ultrasound-guided. The clinician will explain the procedure, medicines and individual aftercare before you decide.
Tell the clinician about previous knee procedures, medical conditions, medicines including blood thinners, allergies, infections and diabetes. Ask how the manufacturer information applies to your circumstances and what alternatives may be appropriate. Do not decide suitability from an abbreviated list on a website.
Sarah is an Orthopaedic Physiotherapy Practitioner and prescriber, with 29 years in musculoskeletal care. She has an NHS role alongside the clinic and has been injecting for over 16 years. The assessment and discussion come before any decision about an Arthrosamid injection.
The existing presentation reports joint pain and swelling as possible side effects. Infection is a potential risk with joint injections. The permanent nature of the implant, possible complications and alternatives should all be discussed before treatment. Ask the clinician what advice applies if you have concerns afterwards.
The studies referenced in the pricing-page sources describe groups of patients rather than a guaranteed individual outcome. Ask about the evidence and its limitations as part of an informed discussion.
The listed total cost is £2,300 for ultrasound-guided Arthrosamid for knee osteoarthritis. This price applies at both the Sheffield and Cowes clinics. The exact pricing description below is shared with the pricing page so the named service and cost remain consistent.
Choose Rapid Health Hub, 119 Wales Road, Kiveton Park, Sheffield S26 6RA, or 2 Mill Hill Road, Cowes PO31 7EA, Isle of Wight. Both clinic pages include a map and directions link. Use the booking page to choose your location in WriteUpp.
You can call 07872 582728 or use WhatsApp with an enquiry. For further reading, use the manufacturer website and the existing pricing-page sources: the supplied May 2025 patient presentation, the cited instructions for use and the cited Bliddal research references.
No. The existing patient information describes Arthrosamid as a permanent injectable hydrogel implant, not a corticosteroid or hyaluronic acid injection.
The ultrasound-guided Arthrosamid service for knee osteoarthritis is listed at £2,300 at both the Sheffield and Cowes clinics, subject to assessment.
No. Full assessment and screening come first. The permanent implant, medical history, medicines, exclusions, possible risks and alternatives need to be discussed.
No. Research describes study groups, not a promise for each person. Results vary and are not guaranteed; discuss the evidence and its limitations with the clinician.